{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "exchange": "NCM", "shortName": "Tiziana Life Sciences Ltd", "longName": "Tiziana Life Sciences Ltd", "messageBoardId": "finmb_261234197", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.5970628, "regularMarketPrice": 0.7901, "marketState": "PRE", "firstTradeDateMilliseconds": 1542724200000, "priceHint": 4, "regularMarketChange": 0.01999998, "regularMarketTime": 1684179900, "regularMarketDayHigh": 0.8108, "regularMarketDayRange": "0.79 - 0.8108", "regularMarketDayLow": 0.79, "regularMarketVolume": 50424, "regularMarketPreviousClose": 0.7701, "bid": 0.0, "ask": 0.0, "bidSize": 12, "askSize": 18, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.79, "averageDailyVolume3Month": 150520, "averageDailyVolume10Day": 35560, "fiftyTwoWeekLowChange": 0.29009998, "fiftyTwoWeekLowChangePercent": 0.58019996, "fiftyTwoWeekRange": "0.5 - 1.39", "fiftyTwoWeekHighChange": -0.5999, "fiftyTwoWeekHighChangePercent": -0.43158275, "fiftyTwoWeekLow": 0.5, "fiftyTwoWeekHigh": 1.39, "earningsTimestamp": 1682560800, "earningsTimestampStart": 1682560800, "earningsTimestampEnd": 1682560800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.14, "epsForward": -0.05, "sharesOutstanding": 100589000, "bookValue": 0.195, "fiftyDayAverage": 0.8612, "fiftyDayAverageChange": -0.0711, "fiftyDayAverageChangePercent": -0.08255922, "twoHundredDayAverage": 0.71915, "twoHundredDayAverageChange": 0.07094997, "twoHundredDayAverageChangePercent": 0.0986581, "marketCap": 82532264, "forwardPE": -15.801999, "priceToBook": 4.051795, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tiziana Life Sciences PLC", "nameChangeDate": "2023-05-15", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Tiziana Life Sciences", "symbol": "TLSA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "14/15 Conduit Street", "city": "London", "zip": "W1S 2XJ", "country": "United Kingdom", "website": "https://www.tizianalifesciences.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-  receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA", "age": 50, "title": "Founder, Exec. Chairman & Interim CEO", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 444000, "fmt": "444k", "longFmt": "444,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andrea  Brancale", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard  Clarkson Ph.D.", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew  Westwell Ph.D.", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Keeren  Shah", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Matthew W. Davis M.D., RPh", "title": "Chief Medical Officer & Acting Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Napoleone  Ferrara M.D.", "age": 65, "title": "Member of Scientific Advisory Board", "yearBorn": 1957, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}